| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,136,295 ) |
| | 2025 | 2025 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL119290 | Smooth Muscle Mineralocorticoid Receptor in Obesity-Induced Vascular Stiffness | 001 | 9 | NIH | 12/17/2024 | $762,388 |
| | 2025 | 2025 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY035702 | Galectin-3 and corneal nerve regeneration | 000 | 2 | NIH | 1/15/2025 | $558,514 |
| | 2025 | 2025 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL166810 | Monitoring Autophagy in the Heart and in Tumors Treated with Potentially Cardiotoxic Chemotherapy | 000 | 2 | NIH | 12/6/2024 | $664,765 |
| | 2025 | 2025 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K23DK128657 | Relation between acute changes in kidney function with clinical outcomes among patients with heart failure | 000 | 3 | NIH | 1/7/2025 | $190,929 |
| | 2025 | 2025 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA289424 | Angiogenin and plexin-B2 in therapeutic resistance and disease relapse of GBM | 000 | 1 | NIH | 12/19/2024 | $532,321 |
| | 2025 | 2025 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL167233 | Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults | 000 | 3 | NIH | 11/22/2024 | $562,927 |
| | 2025 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 002 | 4 | NIH | 12/20/2024 | $696,130 |
| | 2025 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | F32HL165838 | Endothelium as a mediator of BCR-ABL tyrosine kinase inhibitor vascular toxicity | 001 | 3 | NIH | 11/7/2024 | -$83,932 |
| | 2025 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers Among Public Housing Residents | 002 | 5 | NIH | 11/1/2024 | $317,012 |
| | 2025 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HS029319 | Improving Equitable Access to Penicillin Allergy De-Labeling | 000 | 2 | AHRQ | 11/12/2024 | -$3,853 |
| | 2025 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | UH3AT012413 | Remote Tai Chi for Knee Osteoarthritis: an Embedded Pragmatic Trial | 000 | 2 | NIH | 10/18/2024 | $0 |
| | 2025 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R33NS113341 | Discovery of the Biomarker Signature for Neuropathic Corneal Pain | 000 | 3 | NIH | 12/6/2024 | $0 |
| | 2025 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | F32HL165838 | Endothelium as a mediator of BCR-ABL tyrosine kinase inhibitor vascular toxicity | 000 | 2 | NIH | 11/6/2024 | -$10,155 |
| | 2025 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY029269 | Sex Dependent Regulation of Retinol Degeneration | 001 | 5 | NIH | 12/17/2024 | $24,450 |
| | 2025 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | U01TR002271 | Precision Medicine in the Diagnosis of Genetic Disorders in Neonates | 000 | 5 | NIH | 12/13/2024 | -$74,262 |
| | 2025 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL119290 | Smooth Muscle Mineralocorticoid Receptor in Obesity-Induced Vascular Stiffness | 000 | 8 | NIH | 12/16/2024 | $0 |
| | 2025 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R21AG075796 | Endothelial Pannexin1 in Alzheimer’s Disease | 000 | 1 | NIH | 11/25/2024 | $0 |
| | 2025 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY029602 | Mechanisms of Corneal Neuro-Immune Crosstalk | 000 | 5 | NIH | 10/29/2024 | $0 |
| | 2025 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | T7731741 | Developmental-Behavioral Pediatrics Training Program | 02 | 5 | HRSA | 11/12/2024 | -$937 |
| | 2025 | 2021 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HD091054 | Placental lipid metabolism impacts fetal adiposity and is programmed by the maternal metabolic milieu in early pregnancy | 000 | 6 | NIH | 11/19/2024 | $0 |
| | 2025 | 2020 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | U01DK098245 | Vitamin D and Type 2 Diabetes (D2d) | 000 | 8 | NIH | 10/8/2024 | -$1 |
|
| Issue Date FY: 2024 ( Subtotal = $23,037,767 ) (Continued on the next page) |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01NS134859 | Covert Cerebrovascular Disease Detected by Artificial Intelligence (C2D2AI): Pragmatic Neuroimaging Biomarkers for Future Stroke and Dementia Risk | 000 | 1 | NIH | 2/14/2024 | $790,627 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL095590 | The Role of Vascular MR-Regulated Genes in Vascular Function and Disease | 000 | 13 | NIH | 3/22/2024 | $706,071 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL160834 | The sexually dimorphic role of smooth muscle cell estrogen receptor alpha in vascular aging | 000 | 3 | NIH | 5/15/2024 | $680,908 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R03AI176091 | Evaluation of tafenoquine for prophylaxis of babesiosis caused by Babesia microti | 001 | 2 | NIH | 5/10/2024 | $8,900 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R03AI176091 | Evaluation of tafenoquine for prophylaxis of babesiosis caused by Babesia microti | 000 | 2 | NIH | 1/24/2024 | $80,100 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HD109206 | Placental miRNAs paracrine and endocrine roles in insulin sensitivity in pregnancy | 000 | 3 | NIH | 7/16/2024 | $577,364 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K23DA056847 | Sex-specific Impact of Prenatal Opioids on Brain Reward Signaling and Neonatal Feeding Regulation | 000 | 2 | NIH | 2/23/2024 | $191,160 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY034942 | The role of plasmacytoid dendritic cells in corneal immunity | 001 | 2 | NIH | 6/28/2024 | $526,775 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA262265 | Modeling Multi-Source Data in Hodgkin Lymphoma | 001 | 3 | NIH | 4/16/2024 | $33,365 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA262265 | Modeling Multi-Source Data in Hodgkin Lymphoma | 000 | 3 | NIH | 3/1/2024 | $600,535 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL162919 | Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure | 001 | 3 | NIH | 6/21/2024 | $67,518 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL162919 | Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure | 000 | 3 | NIH | 4/11/2024 | $759,586 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA273208 | Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care | 000 | 4 | NIH | 7/11/2024 | $648,684 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | F32HL165838 | Endothelium as a mediator of BCR-ABL tyrosine kinase inhibitor vascular toxicity | 000 | 3 | NIH | 7/10/2024 | $83,932 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K23AR078177 | Targeted Peer Coaching to Reduce Fatigue in Lupus: A Patient-Centered Behavioral Intervention | 001 | 4 | NIH | 8/19/2024 | $155,126 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K23AR078177 | Targeted Peer Coaching to Reduce Fatigue in Lupus: A Patient-Centered Behavioral Intervention | 000 | 3 | NIH | 12/21/2023 | $783 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA271145 | Improving PRO Interpretation at the Individual Level for Patients with Cancer using Conversational Agents and Data Visualization | 001 | 3 | NIH | 4/17/2024 | $34,497 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA271145 | Improving PRO Interpretation at the Individual Level for Patients with Cancer using Conversational Agents and Data Visualization | 000 | 3 | NIH | 2/27/2024 | $620,941 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01DK128208 | The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial | 000 | 4 | NIH | 6/21/2024 | $289,468 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY032502 | Innate Immunomodulation of Retinal Vascular Development | 002 | 4 | NIH | 8/23/2024 | $445,000 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 004 | 4 | NIH | 9/19/2024 | $117,906 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 003 | 4 | NIH | 5/30/2024 | $50,155 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 002 | 4 | NIH | 3/11/2024 | $0 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 001 | 4 | NIH | 2/23/2024 | $644,851 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA245864 | Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody | 000 | 5 | NIH | 5/6/2024 | $497,137 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL149999 | MiR-409-3p Regulates Angiogensis, Brown Fat Adiposity and Insulin Resistance | 000 | 5 | NIH | 5/7/2024 | $598,681 |
| | 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers Among Public Housing Residents | 002 | 5 | NIH | 9/9/2024 | $95,577 |
|
